Wednesday New Pumping Lows

pumping lows

Markets sold off today on weak durable-goods data. Investors are probably ratcheting down GDP expectations as a result. It is interesting to note recent selling pressure in the biotechs. Is that sector taking a breather in its powerful bull market, or is this the start of something more? Legendary Warren Buffett is back in the news today with the recent Heinz-Kraft merger.

Cannabis stocks churned today on lighter volume than yesterday.

Daily Positive: Progress continues north of the border with announcements from two Canadian LPs. Tweed Marijuana Inc. announced partial exercise of the over-allotment option by underwriters. Tweed could not have raised that amount of money that quickly if not for strong institutional investor support.

Aphria announced that it successfully amended its license with Health Canada to allow for wholesale shipping. We see this as a positive opportunity to provide additional revenue generation, which coincides nicely with the company’s recent announcement about expanding operations.

Wow, the low levels people will reach when trying to manipulate an OTC Pink name are truly fantastic. One brand in particular has been pump-pump-pumping away for weeks. However, we found a new pumping low … pumping the stock on under the ruse of a product review:

Two of three people found that review to be helpful?

The press release that the product “has been restocked at” is inane, but we still worry that people will see it as substantive. Just take a moment to reflect on what the press would be like if every company put out a release every time restocked its products. We would be drowning in even more useless information. As an investor, take the time to dig deeper.


The discussion above is provided for informational purposes only and does not constitute an offer of, or solicitation for, any investment services or products offered by the author. The author is not making any investment recommendations and the opinions above do not constitute investment advice. Reference to above indices [and companies] is based on information provided by sources the author believes to be credible. Investing in the cannabis industry, as with other industries, presents certain risks including the risk of loss on an investment.

Morgan is a Founding Partner and Managing Director of Poseidon Asset Management. He is the Chief Investor of their Cannabis Focused Fund. Morgan previously worked for a privately owned Registered Investment Adviser and earlier was at UBS Financial Services focusing on wealth management. Morgan believes in the potential of the cannabis industry and likes having an active involvement as it develops. You can follow him on Twitter @PoseidonAsset.

Related posts